Published in J Int Neuropsychol Soc on April 07, 2010
Diagnostic accuracy statistics for seven Neuropsychological Assessment Battery (NAB) test variables in the diagnosis of Alzheimer's disease. Appl Neuropsychol Adult (2012) 0.77
Practice Effects on Story Memory and List Learning Tests in the Neuropsychological Assessment of Older Adults. PLoS One (2016) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol (2007) 18.62
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology (1989) 16.83
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med (2004) 16.58
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology (1992) 9.30
The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery. Alzheimer Dis Assoc Disord (2009) 5.50
Plaques, tangles and dementia. A quantitative study. J Neurol Sci (1982) 4.52
Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch Neurol (2003) 3.47
Education delays accelerated decline on a memory test in persons who develop dementia. Neurology (2007) 1.87
Mild cognitive impairment is early-stage Alzheimer disease: time to revise diagnostic criteria. Arch Neurol (2006) 1.80
Age at onset of Alzheimer's disease: relation to pattern of cognitive dysfunction and rate of decline. Neurology (1994) 1.60
Memory dysfunction. N Engl J Med (2005) 1.46
Disease-modifying therapies in Alzheimer's disease. Alzheimers Dement (2008) 1.39
The effects of age on rate of progression of Alzheimer disease and dementia with associated cerebrovascular disease. Arch Neurol (2001) 1.35
The effect of education and occupational complexity on rate of cognitive decline in Alzheimer's patients. J Int Neuropsychol Soc (2006) 1.31
Cognitive correlates of HVOT performance differ between individuals with mild cognitive impairment and normal controls. Arch Clin Neuropsychol (2006) 1.26
Alzheimer's disease. Semin Neurol (2007) 1.25
Verbal fluency patterns in amnestic mild cognitive impairment are characteristic of Alzheimer's type dementia. J Int Neuropsychol Soc (2006) 1.24
Visuospatial deficits predict rate of cognitive decline in autopsy-verified dementia with Lewy bodies. Neuropsychology (2008) 1.03
Diagnostic utility of the NAB List Learning test in Alzheimer's disease and amnestic mild cognitive impairment. J Int Neuropsychol Soc (2009) 1.02
Identifying patients at high and low risk of cognitive decline using Rey Auditory Verbal Learning Test among middle-aged memory clinic outpatients. Dement Geriatr Cogn Disord (2006) 0.88
Mild cognitive impairment and functional status. J Am Geriatr Soc (2006) 0.85
Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol (2009) 11.05
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet (2007) 9.80
Managing incidental findings and research results in genomic research involving biobanks and archived data sets. Genet Med (2012) 9.65
Chronic traumatic encephalopathy in blast-exposed military veterans and a blast neurotrauma mouse model. Sci Transl Med (2012) 6.27
Surgery versus physical therapy for a meniscal tear and osteoarthritis. N Engl J Med (2013) 6.08
Diagnostic clinical genome and exome sequencing. N Engl J Med (2014) 5.55
Protective variant for hippocampal atrophy identified by whole exome sequencing. Ann Neurol (2015) 5.10
The spectrum of disease in chronic traumatic encephalopathy. Brain (2012) 5.10
TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol (2010) 4.48
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement (2011) 4.25
Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans. Alzheimers Dement (2010) 3.11
The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med (2009) 2.91
Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL study. Genet Med (2004) 2.82
Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans. Alzheimers Dement (2010) 2.79
Disclosing pathogenic genetic variants to research participants: quantifying an emerging ethical responsibility. Genome Res (2012) 2.76
Point-counterpoint. Ethics and genomic incidental findings. Science (2013) 2.73
Chronic traumatic encephalopathy: a potential late effect of sport-related concussive and subconcussive head trauma. Clin Sports Med (2011) 2.60
Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. JAMA (2013) 2.58
Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial. Genet Med (2004) 2.44
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement (2013) 2.32
Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study. Alzheimer Dis Assoc Disord (2008) 2.30
Chronic traumatic encephalopathy: neurodegeneration following repetitive concussive and subconcussive brain trauma. Brain Imaging Behav (2012) 2.16
Hippocampal sclerosis in advanced age: clinical and pathological features. Brain (2011) 2.16
Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium. Genet Med (2013) 2.08
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
Screening and brief intervention online for college students: the ihealth study. Alcohol Alcohol (2006) 2.06
Capture-recapture estimates of nonfatal workplace injuries and illnesses. Ann Epidemiol (2008) 2.05
Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study. J Geriatr Psychiatry Neurol (2005) 2.03
Evidence-based tool for triggering school closures during influenza outbreaks, Japan. Emerg Infect Dis (2009) 2.02
Direct to consumer genetic testing: Avoiding a culture war. Genet Med (2009) 2.00
Researcher judgment and study design: challenges of using administrative data. Am J Ind Med (2010) 1.98
Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior. Health Aff (Millwood) (2005) 1.93
Relation of brachial and digital measures of vascular function in the community: the Framingham heart study. Hypertension (2011) 1.90
Cancer survivorship and sexual orientation. Cancer (2011) 1.89
Extended results of the Alzheimer's disease anti-inflammatory prevention trial. Alzheimers Dement (2011) 1.87
Characterization of activities of daily living in individuals with mild cognitive impairment. Am J Geriatr Psychiatry (2008) 1.86
Methodological Considerations in Studying Centenarians: Lessons Learned From the Georgia Centenarian Studies. Annu Rev Gerontol Geriatr (2007) 1.85
Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study. Am J Geriatr Psychiatry (2011) 1.83
Reasons for seeking genetic susceptibility testing among first-degree relatives of people with Alzheimer disease. Alzheimer Dis Assoc Disord (2003) 1.79
Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study. Arch Neurol (2006) 1.78
Trail Making Test errors in normal aging, mild cognitive impairment, and dementia. Arch Clin Neuropsychol (2008) 1.69
Genetic testing for Alzheimer's and long-term care insurance. Health Aff (Millwood) (2010) 1.67
The use of vertebral augmentation and external beam radiation therapy in the multimodal management of malignant vertebral compression fractures. Pain Physician (2011) 1.67
Using AD biomarker research results for clinical care: a survey of ADNI investigators. Neurology (2013) 1.63
Regulation: The FDA is overcautious on consumer genomics. Nature (2014) 1.52
Dural arteriovenous fistulas: a review of the literature and a presentation of a single institution's experience. World Neurosurg (2012) 1.50
Predicting road test performance in adults with cognitive or visual impairment referred to a Veterans Affairs Medical Center driving clinic. J Am Geriatr Soc (2012) 1.50
Risk-adjusted percent time in therapeutic range as a quality indicator for outpatient oral anticoagulation: results of the Veterans Affairs Study to Improve Anticoagulation (VARIA). Circ Cardiovasc Qual Outcomes (2010) 1.50
Epidemiology of apathy in older adults: the Cache County Study. Am J Geriatr Psychiatry (2007) 1.50
Endothelial function and white matter hyperintensities in older adults with cardiovascular disease. Stroke (2007) 1.49
Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial. Ann Intern Med (2016) 1.47
Personalized genetic risk counseling to motivate diabetes prevention: a randomized trial. Diabetes Care (2012) 1.46
Palliation of compression fractures in cancer patients by vertebral augmentation: a retrospective analysis. J Neurointerv Surg (2010) 1.45
P-selectin 1087G/A polymorphism is associated with neuropsychological test performance in older adults with cardiovascular disease. Stroke (2009) 1.43
Mild traumatic brain injury: a risk factor for neurodegeneration. Alzheimers Res Ther (2010) 1.43
Conceptual and measurement challenges in research on cognitive reserve. J Int Neuropsychol Soc (2011) 1.43
Predicting outcomes among patients with atrial fibrillation and heart failure receiving anticoagulation with warfarin. Thromb Haemost (2015) 1.42
Evaluating elements of executive functioning as predictors of instrumental activities of daily living (IADLs). Arch Clin Neuropsychol (2006) 1.40
The future of direct-to-consumer clinical genetic tests. Nat Rev Genet (2011) 1.38
Association between apolipoprotein E genotype and Alzheimer disease in African American subjects. Arch Neurol (2002) 1.37
Decisional capacity for research participation in individuals with mild cognitive impairment. J Am Geriatr Soc (2008) 1.35
The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE ε3/ε3 genotype. Alzheimers Dement (2011) 1.35
The adult galactosemic phenotype. J Inherit Metab Dis (2011) 1.34
Caregiver-recipient closeness and symptom progression in Alzheimer disease. The Cache County Dementia Progression Study. J Gerontol B Psychol Sci Soc Sci (2009) 1.33
Communicating genetic risk information for common disorders in the era of genomic medicine. Annu Rev Genomics Hum Genet (2013) 1.33
Clock drawing test ratings by dementia specialists: interrater reliability and diagnostic accuracy. J Neuropsychiatry Clin Neurosci (2010) 1.33
Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast. Radiology (2010) 1.33
A comprehensive genetic association study of Alzheimer disease in African Americans. Arch Neurol (2011) 1.33
Vascular and cognitive functions associated with cardiovascular disease in the elderly. J Clin Exp Neuropsychol (2008) 1.33
Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis. Am J Cardiol (2008) 1.31
The IL12B gene is associated with asthma. Am J Hum Genet (2004) 1.29
Apathy is associated with volume of the nucleus accumbens in patients infected with HIV. J Neuropsychiatry Clin Neurosci (2005) 1.29
Carotid artery intima-media thickness and cognition in cardiovascular disease. Int J Cardiol (2006) 1.28
Potential impact of amyloid imaging on diagnosis and intended management in patients with progressive cognitive decline. Alzheimer Dis Assoc Disord (2013) 1.28
Genome-wide scan of healthy human connectome discovers SPON1 gene variant influencing dementia severity. Proc Natl Acad Sci U S A (2013) 1.26
Genetic susceptibility testing for Alzheimer disease: motivation to obtain information and control as precursors to coping with increased risk. Patient Educ Couns (2006) 1.26
Cognitive correlates of HVOT performance differ between individuals with mild cognitive impairment and normal controls. Arch Clin Neuropsychol (2006) 1.26
The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI). Front Aging Neurosci (2013) 1.26
Development and validation of a computational method for assessment of missense variants in hypertrophic cardiomyopathy. Am J Hum Genet (2011) 1.25
Effect of Alzheimer disease genetic risk disclosure on dietary supplement use. Am J Clin Nutr (2010) 1.25
Predictive genetic testing for Alzheimer's disease: impact upon risk perception. Risk Anal (2005) 1.25
Diagnostic clinical genome and exome sequencing. N Engl J Med (2014) 1.24
Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers. Brain Imaging Behav (2014) 1.23
Population-based study of medical comorbidity in early dementia and "cognitive impairment, no dementia (CIND)": association with functional and cognitive impairment: The Cache County Study. Am J Geriatr Psychiatry (2005) 1.23
C-reactive protein, but not homocysteine, is related to cognitive dysfunction in older adults with cardiovascular disease. J Clin Neurosci (2006) 1.22
Differences between African Americans and whites in their perceptions of Alzheimer disease. Alzheimer Dis Assoc Disord (2003) 1.21
Substance use among Asian Americans and Pacific Islanders sexual minority adolescents: findings from the National Longitudinal Study of Adolescent Health. J Adolesc Health (2008) 1.20
Soft tissue, joint, and bone manifestations of AL amyloidosis: clinical presentation, molecular features, and survival. Arthritis Rheum (2007) 1.20
Profile of self-reported problems with executive functioning in college and professional football players. J Neurotrauma (2013) 1.19
Acute effects of vasoactive drug treatment on brachial artery reactivity. J Am Coll Cardiol (2002) 1.19
"I know what you told me, but this is what I think:" perceived risk of Alzheimer disease among individuals who accurately recall their genetics-based risk estimate. Genet Med (2010) 1.19